Chiu-Mei Sung
South College(US)GlaxoSmithKline (United States)(US)Cytokinetics (United States)(US)
Publications by Year
Research Areas
Metabolism and Genetic Disorders, Peroxisome Proliferator-Activated Receptors, Metal complexes synthesis and properties, Microtubule and mitosis dynamics, PI3K/AKT/mTOR signaling in cancer
Most-Cited Works
- → Discovery of GSK2126458, a Highly Potent Inhibitor of PI3K and the Mammalian Target of Rapamycin(2010)368 cited
- → Identification of Novel Isoform-Selective Inhibitors within Class I Histone Deacetylases(2003)350 cited
- → Cloning and Characterization of a Novel Human Class I Histone Deacetylase That Functions as a Transcription Repressor(2000)301 cited
- In vivo antitumor activity and in vitro cytotoxic properties of bis[1,2-bis(diphenylphosphino)ethane]gold(I) chloride.(1986)
- → Potent and Selective Nonpeptide Inhibitors of Caspases 3 and 7 Inhibit Apoptosis and Maintain Cell Functionality(2000)232 cited
- → Potent and Selective Nonpeptide Inhibitors of Caspases 3 and 7(2001)164 cited
- → Discovery of the First Potent and Selective Inhibitor of Centromere-Associated Protein E: GSK923295(2010)64 cited